Page last updated: 2024-10-26

dipyridamole and Hematuria

dipyridamole has been researched along with Hematuria in 13 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Hematuria: Presence of blood in the urine.

Research Excerpts

ExcerptRelevanceReference
"Dan Shao Tang is effective to treatment on simple hematuria of masked nephritis of dificiency of Yin with damp-heat symptom effectively."2.70[The clinical study on Dan Shao Tang in treating simple hematuria of masked nephritis of deficiency of Yin with damp-heat symptom]. ( Li, J; Mo, S; Shen, W; Wu, X, 2002)
"Treatment with prednisolone, azathioprine, heparin-warfarin, and dipyridamole early in the course of disease may prevent immunologic renal injury in children with severe IgA nephropathy."2.69A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group. ( Awazu, M; Hattori, S; Honda, M; Iitaka, K; Ito, H; Ito, K; Koitabashi, Y; Matsuyama, S; Nakagawa, K; Nakamura, H; Ninomiya, M; Sakai, T; Seino, Y; Takeda, N; Takekoshi, Y; Yamaoka, K; Yoshikawa, N, 1999)
"We enrolled 35 patients with MPGN type 1 who had a normal creatinine clearance at the time of their first renal biopsy and divided them into 2 groups based on clinical status at the time of their most recent examination: 12 patients with normal urine test results and 12 patients with minor urinary abnormalities at the latest observation (group 1) and 7 patients with persistent nephropathy and 4 patients with renal insufficiency (group 2)."1.33Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1. ( Hosoya, M; Isome, M; Kawasaki, Y; Suzuki, H; Takahashi, A; Tanji, M, 2005)
"Patients with type II MPGN are usually difficult to treat and often progress to endstage renal failure."1.32Long-term follow-up of type II membranoproliferative glomerulonephritis in two children. ( Iitaka, K; Iwasaki, N; Koshino, H; Moriya, S; Motoyama, O; Nakamura, S; Sakai, T, 2003)
"Three years after the initiation of treatment, proteinuria and hematuria had significantly decreased in both groups, and the renal function in Group B was significantly improved."1.29Early intensive therapy for clinical remission of active IgA nephropathy: a three-year follow-up study. ( Horigome, I; Hotta, O; Kurosawa, K; Sudo, K; Suzuki, K; Taguma, Y, 1993)

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19906 (46.15)18.7374
1990's3 (23.08)18.2507
2000's4 (30.77)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iitaka, K3
Nakamura, S1
Moriya, S1
Koshino, H1
Iwasaki, N1
Motoyama, O2
Sakai, T2
Wu, X1
Li, J1
Mo, S1
Shen, W1
Kawasaki, Y1
Hosoya, M1
Takahashi, A1
Isome, M1
Tanji, M1
Suzuki, H1
Kojima, Y1
Ohara, A1
Tsukimoto, I1
Ishikawa, Y1
Oner, A1
Tinaztepe, K1
Erdogan, O1
Hotta, O1
Taguma, Y1
Kurosawa, K1
Sudo, K1
Suzuki, K1
Horigome, I1
Yoshikawa, N1
Ito, H1
Takekoshi, Y1
Honda, M1
Awazu, M1
Ito, K1
Koitabashi, Y1
Yamaoka, K1
Nakagawa, K1
Nakamura, H1
Matsuyama, S1
Seino, Y1
Takeda, N1
Hattori, S1
Ninomiya, M1
Yagame, M1
Tomino, Y2
Miura, M1
Suga, T1
Endoh, M1
Nomoto, Y1
Sakai, H2
Hanzawa, S1
Ohno, J1
Kitajima, T1
Sakai, O1
Kan, K1
Wada, T1
Kitamoto, K1
Konishi, K1
Ozawa, Y1
Kalowski, S1
Kincaid-Smith, P2
Howenstine, JA1
Slaton, P1
Spitalny, A1
Lee, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phase IV Open Label Uncontrolled Trial of the Dual Blockade of the Renin Angiotensin System With Enalapril Plus Valsartan Combined With Oral Methylprednisolone for the Treatment of Proteinuria in IGA Nephropathy[NCT00367562]Phase 420 participants Interventional1996-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

4 trials available for dipyridamole and Hematuria

ArticleYear
[The clinical study on Dan Shao Tang in treating simple hematuria of masked nephritis of deficiency of Yin with damp-heat symptom].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2002, Volume: 25, Issue:11

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Aspirin; Dipyridamole; Drug Combinations; Drug Therapy, C

2002
The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis.
    Pediatric nephrology (Berlin, Germany), 1995, Volume: 9, Issue:1

    Topics: Adolescent; Child; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephr

1995
A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Journal of the American Society of Nephrology : JASN, 1999, Volume: 10, Issue:1

    Topics: Adolescent; Azathioprine; Blood Urea Nitrogen; Child; Dipyridamole; Drug Therapy, Combination; Glome

1999
Clinical effect of danazol in patients with IgA nephropathy.
    Japanese journal of medicine, 1987, Volume: 26, Issue:2

    Topics: Administration, Oral; Adult; Clinical Trials as Topic; Complement C3; Complement C4; Danazol; Dipyri

1987

Other Studies

9 other studies available for dipyridamole and Hematuria

ArticleYear
Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
    Clinical and experimental nephrology, 2003, Volume: 7, Issue:1

    Topics: Basement Membrane; Biopsy; Child; Dipyridamole; Female; Follow-Up Studies; Glomerular Mesangium; Glo

2003
Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 45, Issue:3

    Topics: Adolescent; Aspirin; Biomarkers; Biopsy; Calgranulin A; Calgranulin B; Child; Creatinine; Cyclophosp

2005
IgA nephropathy associated with leukemia and lymphoma: report of two cases.
    Clinical and experimental nephrology, 2008, Volume: 12, Issue:2

    Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Di

2008
Early intensive therapy for clinical remission of active IgA nephropathy: a three-year follow-up study.
    Nihon Jinzo Gakkai shi, 1993, Volume: 35, Issue:8

    Topics: Adolescent; Adult; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Stud

1993
Clinical effect of dipyridamole in patients with IgA nephropathy.
    The Tokai journal of experimental and clinical medicine, 1986, Volume: 11, Issue:5

    Topics: Adrenochrome; Dipyridamole; Glomerulonephritis; Glomerulonephritis, IGA; Hematuria; Humans; Proteinu

1986
Dipyridamole for proteinuria suppression. Use in a patient with proliferative glomerulonephritis.
    JAMA, 1974, Jul-29, Volume: 229, Issue:5

    Topics: Adolescent; Biopsy; Dipyridamole; Glomerulonephritis; Hematuria; Humans; Kidney Glomerulus; Male; Pr

1974
Interaction of dipyridamole with anticoagulants in the treatment of glomerulonephritis.
    The Medical journal of Australia, 1973, Jul-28, Volume: 2, Issue:4

    Topics: Adolescent; Adult; Contusions; Dipyridamole; Drug Interactions; Epistaxis; Female; Glomerulonephriti

1973
Flank pain and hematuria in a young man with renal artery arteriosclerosis: remission of symptoms during administration of dipyridamole.
    The Journal of urology, 1974, Volume: 112, Issue:1

    Topics: Adult; Angiography; Arteriosclerosis; Dipyridamole; Hematuria; Hemorrhage; Humans; Ischemia; Kidney;

1974
The treatment of chronic mesangiocapillary (membranoproliferative) glomerulonephritis with impaired renal function.
    The Medical journal of Australia, 1972, Sep-09, Volume: 2, Issue:11

    Topics: Anticoagulants; Biopsy; Cyclophosphamide; Dipyridamole; Drug Combinations; Erythrocyte Count; Female

1972